India, Oct. 6 -- The global demand for Vitamin D3 is being supported by rising health awareness, increasing nutritional supplement adoption and growing concerns around Vitamin D deficiency. This has created opportunities for manufacturers serving pharmaceutical, nutraceutical and food applications.

Fermenta Biotech Ltd is one of the established players in this space, with a presence across international markets. The company is also expanding its product portfolio and manufacturing capacity as it looks to tap emerging opportunities in human nutrition and plant-based Vitamin D products.

With a market capitalisation of Rs. 1,635 cr, the shares of Fermenta Biotech Ltd were trading at Rs. 555.60 per share, down from its previous close of Rs...